APA (7th ed.) Citation

N. V. Kungurov, N. V. Zilberberg, M. M. Kokhan, J. V. Keniksfest, & E. V. Grishaeva. (2019). Experience in the treatment of psoriasis patients using Apremilast, a selective signalling pathway inhibitor. State Scientific Center of Dermatovenereology and Cosmetology.

Chicago Style (17th ed.) Citation

N. V. Kungurov, N. V. Zilberberg, M. M. Kokhan, J. V. Keniksfest, and E. V. Grishaeva. Experience in the Treatment of Psoriasis Patients Using Apremilast, a Selective Signalling Pathway Inhibitor. State Scientific Center of Dermatovenereology and Cosmetology, 2019.

MLA (9th ed.) Citation

N. V. Kungurov, et al. Experience in the Treatment of Psoriasis Patients Using Apremilast, a Selective Signalling Pathway Inhibitor. State Scientific Center of Dermatovenereology and Cosmetology, 2019.